Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy
about
The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implicationsImmune Cells in Cancer Therapy and Drug DeliveryNeutrophils in Cancer: Two Sides of the Same CoinDistinct Functions of Neutrophil in Cancer and Its RegulationTargeting the Fc receptor in autoimmune diseaseThe Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentImmunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma.Monocyte activation in patients with Wegener's granulomatosis.Systemic T cell-independent tumor immunity after transplantation of universal receptor-modified bone marrow into SCID mice.Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancerColorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosisAntigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.Chimaeric Lym-1 monoclonal antibody-mediated cytolysis by neutrophils from G-CSF-treated patients: stimulation by GM-CSF and role of Fc gamma -receptors.FMLP- and TNF-stimulated monoclonal Lym-1 antibody-dependent lysis of B lymphoblastoid tumour targets by neutrophils.Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab.The regulation of pre-metastatic niche formation by neutrophils.
P2860
Q24605052-710F61B5-8E97-4E80-BAFB-F1CE44BC7ED8Q26747061-C3C30538-44D5-446C-A1E8-8E257E7C0819Q26773072-70CAD507-D930-421E-9EF4-E6830A5193A5Q26773228-4FF85D15-92A6-4CCB-AC9B-449CF47357A6Q27002843-D0D14199-6E12-4EDA-B4EA-901DA6229F14Q28241308-51D1C660-71D3-4A34-B93D-785056DE2844Q33627797-045D3D8B-D40F-45D2-A411-B71E6450C7F0Q35548500-47F2AAF3-6C34-41A4-9380-4341E88A8B5EQ36377445-F7700AF6-6020-42E9-986E-F39CA3001543Q36673566-29F6A6F0-7A18-4B1A-9549-9B836CF788F9Q37302680-80F7515D-39E7-4BC9-A48D-013AC83F6BABQ37350204-05E15E47-ECCE-4E32-B43A-3A760452D795Q42026336-95C1221D-4473-48CE-BA32-165702DE9FF7Q42033770-3FC4E5DA-263B-4C75-AE0B-89B4DC8B6370Q42635839-C6B83D3E-01DB-425F-B0F8-5E25550FCA54Q49265524-5612C1CC-59F1-46D6-A8F7-7AEB75528BC6
P2860
Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Involvement of the high-affini ...... ony-stimulating factor therapy
@ast
Involvement of the high-affini ...... ony-stimulating factor therapy
@en
Involvement of the high-affini ...... ony-stimulating factor therapy
@nl
type
label
Involvement of the high-affini ...... ony-stimulating factor therapy
@ast
Involvement of the high-affini ...... ony-stimulating factor therapy
@en
Involvement of the high-affini ...... ony-stimulating factor therapy
@nl
prefLabel
Involvement of the high-affini ...... ony-stimulating factor therapy
@ast
Involvement of the high-affini ...... ony-stimulating factor therapy
@en
Involvement of the high-affini ...... ony-stimulating factor therapy
@nl
P2093
P3181
P1433
P1476
Involvement of the high-affini ...... ony-stimulating factor therapy
@en
P2093
J G van de Winkel
J R Kalden
M Gramatzki
S Berthold
T P de Wit
T Valerius
P3181
P407
P577
1993-08-01T00:00:00Z